Bioventus Inc. Class A (BVS) Financials

$13.83

$-0.24 (-1.71%)

As on 08-Sep-2026 16:00EDT

Market cap

$961 Mln

Revenue (TTM)

$582 Mln

P/E Ratio

18.5

P/B Ratio

4.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	581.85	568.09	573.28	512.35	512.12	430.90
Cost of Revenue	186.20	185.66	185.05	184.15	181.04	128.19
Gross Profit	395.64	382.43	388.23	328.19	331.08	302.71
Operating Expenses	333.81	323.88	400.21	409.92	498.31	290.65
Operating Profit (EBIT)	61.83	58.55	-11.98	-81.73	-167.23	12.06
Other Income	--	--	--	--	--	-3.33
Profit before Tax	38.64	25.71	-49.13	-121.11	-189.03	9.49
Provision for Tax	-22.84	-1.57	-5.29	0.09	-44.37	-1.97
Profit after Tax (Net Income)	54.46	22.73	-33.54	-156.23	-158.70	19.38
Minority Interest	-7.01	-4.54	10.29	50.78	54.69	-9.79
Consolidated Profit	--	--	--	--	--	19.38

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	228.31	184.11	147.94	173.59	325.24	458.92
Minority Interest	-7.01	--	--	--	--	74.87
Non-Current Liabilities	243.48	294.73	331.95	414.30	656.41	511.21
Current Liabilities	152.45	160.38	210.40	175.50	304.02	180.86
Total Liabilities	825.80	683.56	727.96	810.91	1,372.65	1,225.86

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	415.82	410.72	452.35	542.91	1,100.07	962.76
Current Assets	257.53	272.84	275.61	268.00	272.58	263.10
Total Assets	825.80	683.56	727.96	810.91	1,372.65	1,225.86
Total Debt*	263.75	311.35	335.63	394.85	418.07	357.68
Net Current Assets	105.08	112.46	65.21	92.50	-31.44	82.24

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	73.98	38.80	15.34	-13.54	22.99
Cash Flow from Investing Activities	--	-3.25	22.96	15.81	-116.44	-283.76
Cash from Financing Activities	--	-61.44	-54.58	-26.65	62.08	273.37
Net Cash Inflow / Outflow	--	--	--	--	--	12.60

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.78	0.33	-0.51	-2.48	-2.56	0.35
Cash EPS ($)	--	1.01	0.24	-1.32	-1.48	0.99
Adjusted Book Value ($)	--	2.67	2.26	2.75	5.25	8.38
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	1.07	0.59	0.24	-0.22	0.42
Free Cash Flow per Share ($)	--	1.04	0.58	0.13	-0.24	0.29

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	4.64	-6.38	-23.82	-20.35	3.38
ROE (%)	23.01	13.69	-20.86	-62.64	-40.48	6.45
ROA (%)	6.34	3.22	-4.36	-14.31	-12.21	2.25
EBIT Margin (%)	6.73	9.19	-1.80	-15.70	-34.56	2.46
Net Margin (%)	9.36	4.00	-5.85	-30.49	-30.99	4.53
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	3.14	-0.01	0.12	0.00	0.19	0.34
EBIT Growth (%)	9.24	605.08	87.15	54.56	-1,769.85	-58.70
Net Profit Growth (%)	9,104.36	167.77	78.53	1.56	-919.12	18.06
EPS Growth (%)	10,561.83	1.64	0.79	0.03	-8.24	-0.19
Book Value Growth (%)	36.99	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	18.51	22.56	-20.49	-2.13	-1.02	40.93
Price / Book Value	4.30	2.78	4.65	1.91	0.50	1.73
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	13.75	7.79	25.02	-29.91	-4.52	24.34
Close Price ($)	9.44	7.44	10.50	5.27	2.61	14.49
High Price ($)	11.25	11.25	14.38	5.54	15.57	19.94
Low Price ($)	5.81	5.81	3.90	0.80	1.65	10.74
Market Cap ($ Cr)	961.05	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	1.01	1.69	2.27	2.27	1.29	0.78
Short term debt to equity ratio	0.10	0.10	0.18	0.16	0.10	0.04
Current Ratio	1.69	1.70	1.31	1.53	0.90	1.45
Quick Ratio	1.17	1.19	0.87	1.01	0.62	1.11
Interest Coverage	2.94	1.97	-0.27	-1.98	-14.72	9.53

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	23.79	22.59	22.22	23.97	26.61	29.00
Asset Turnover	0.68	0.80	0.75	0.47	0.39	0.50
Receivable days	--	82.20	79.70	92.35	93.17	90.38
Inventory Days	--	171.86	181.40	174.64	147.74	129.37
Payable days	--	34.05	46.11	59.24	54.08	30.40
Cash Conversion Cycle	--	220.00	214.98	207.75	186.82	189.35

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.